Luminis Health downgraded as operating performance remains pressured

Annapolis, Md.-based Luminis Health was downgraded from “A” to “A-” amid “consistently negative operating performance and modest cash flow,” according to S&P Global in an Oct. 25 report.

Advertisement

Ongoing labor and inflationary pressures are likely to keep operating performance pressured even as management takes initiatives to stem losses, S&P said. The outlook is stable.

The two-hospital system, anchored by the 447-bed Anne Arundel Medical Center, reported an operating loss of $56.6 million on revenues of $1.1 billion, an operating margin of -5.1%, in fiscal 2023 ending June 30.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.